Oncology

The global cancer burden of adolescents and young adults is projected to increase by approximately 12% by 2050, according to a Nov. 15 study published in The Lancet Oncology. 

Penn Medicine Lancaster (Pa.) General Health has named Efrat Dotan, MD, as executive medical director of the Ann B. Barshinger Cancer Institute.

Compared to primary care physicians, dermatologists have 13.3-fold higher accuracy when diagnosing melanoma using dermoscopic images, according to a study published Nov. 13 in JAMA Dermatology. 

Bryan Bell, MD, DDS, has accepted the roles of executive medical director of Providence Cancer Institute and director of its research arm, the Earle A. Chiles Research Institute, both based in Portland, Ore., according to a news release shared with…

The University of Chicago Medicine Comprehensive Cancer Center has partnered with the Energy Department to harness the technology of the department's Argonne National Laboratory toward the development of treatments for drug-resistant cancers.

Researchers from Chicago-based Northwestern Medicine Canning Thoracic Institute found that the COVID-19 virus triggers the development of a unique immune cell with anti-cancer properties, it said in a Nov. 15 system news release.

Seattle-based Fred Hutch Cancer Center named Nicole Fleming, MD, as its inaugural deputy chief medical officer.

When diagnosed with prostate cancer, men with limited life expectancy are being overtreated, according to a study published Nov. 11 in JAMA Internal Medicine. 

Among the many factors at play in overcoming cancer care gaps in the U.S., increased screening and access to care are top of mind. However, cancer trial participation is also crucial. 

An FDA advisory panel endorsed a minimally invasive breast cancer surgery alternative at a Nov. 7 meeting.